ASCENTAGE PHARMA GROUP INTL SPON ADS EACH REP 4 ORD SHS WHEN ISSUEDASCENTAGE PHARMA GROUP INTL SPON ADS EACH REP 4 ORD SHS WHEN ISSUEDASCENTAGE PHARMA GROUP INTL SPON ADS EACH REP 4 ORD SHS WHEN ISSUED

ASCENTAGE PHARMA GROUP INTL SPON ADS EACH REP 4 ORD SHS WHEN ISSUED

No trades
See on Supercharts
Market capitalization
‪1.47 B‬USD
−0.69USD
‪−130.65 M‬USD
‪31.33 M‬USD
Beta (1Y)

About ASCENTAGE PHARMA GROUP INTL SPON ADS EACH REP 4 ORD SHS WHEN ISSUED


CEO
Da Jan Yang
Headquarters
Suzhou
Founded
2009
FIGI
BBG01RJXM9C9
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.